B2M and amyloidosis: Serum B2M is regarded as a biomarker for the severity of infections, amyloidosis, renal injury, lymphoproliferative diseases, and aging-related disorders (23, 32), while the B2M on the cell membrane surface non-covalently binds to the heavy chain of MHC-I molecule to execute diverse immune functions.